Results 71 to 80 of about 17,817 (253)

Predicting Significant Blood Pressure Reduction Through Ambulatory Blood Pressure Monitoring in Patients With Obstructive Sleep Apnea Treated With Continuous Positive Airway Pressure

open access: yesThe Clinical Respiratory Journal, Volume 20, Issue 1, January 2026.
CPAP therapy induces a modest reduction in blood pressure among patients with OSA. Patients with a baseline 24‐h MAP of ≥ 96 mmHg experience greater absolute and relative reductions in all blood pressure measures after CPAP treatment than those with a lower MAP. ABSTRACT Objective Continuous positive airway pressure (CPAP) therapy for obstructive sleep
Yuanni Jiao   +5 more
wiley   +1 more source

Junctional Bradycardia as Early Sign of Digoxin Toxicity in a Premature Infant with Congestive Heart Failure due to a Left to Right Shunt

open access: yesAmerican Journal of Perinatology Reports, 2016
Introduction Congestive heart failure due to left to right cardiac shunt is usually managed medically with diuretics, angiotensin converting enzyme inhibitors, and, in some cases, with the addition of digoxin.
Soham Dasgupta   +2 more
doaj   +1 more source

A case report of malignant hypertension in a young woman [PDF]

open access: yes, 2016
8noMalignant hypertension is a condition characterized by severe hypertension and multi-organ ischemic complications. Albeit mortality and renal survival have improved with antihypertensive therapy, progression to end-stage renal disease remains a ...
Bardelli, Moreno   +7 more
core   +2 more sources

Eplerenone improves kidney function and cardiac performance in obese male mice

open access: yesDiabetic Medicine, Volume 43, Issue 1, January 2026.
Abstract Aims Renin‐angiotensin‐aldosterone system (RAAS) activation mediates obesity‐associated cardiorenal dysfunction. Due to an incomplete understanding of the molecular mechanisms, the clinical use of RAAS antagonism in obesity‐associated cardiometabolic complications remains uncertain.
Ayman K. Banah   +8 more
wiley   +1 more source

Hyperaldosteronism

open access: yes
Leslie SW, Muppidi V, Gupta S.
europepmc   +2 more sources

Trained Immunity and Cardiovascular Risk: An Immunological Perspective

open access: yesImmunological Reviews, Volume 337, Issue 1, January 2026.
ABSTRACT Systemic inflammation is a key driver of atherogenesis and its complications. While anti‐inflammatory therapies targeting pathways such as IL‐1β and IL‐6 have shown promise in established atherosclerotic cardiovascular disease (ASCVD), potential systemic effects raise concerns about immune suppression and infection, underscoring the need for ...
Katherine A. Boden   +3 more
wiley   +1 more source

Neoadjuvant chemotherapy and salvage surgery for an aldosterone-producing adrenal carcinoma with inferior vena cava thrombus: Case report and literature review

open access: yesAsian Journal of Surgery, 2013
Inferior vena cava (IVC) thrombus is a rare presentation of adrenal carcinoma. Hyperladosteronism is rarely associated with it. We report a case of an aldosterone-producing left adrenal carcinoma with IVC thrombus and invasion of multiple organs, treated
Carlos Rangel   +4 more
doaj   +1 more source

Confounders of the aldosterone‐to‐renin ratio when used as a screening test in hypertensive patients: A critical analysis of the literature

open access: yesThe Journal of Clinical Hypertension, 2021
The aldosterone‐to‐renin ratio (ARR) is a common screening test for primary aldosteronism in hypertensives. However, there are many factors which could confound the ARR test result and reduce the accuracy of this test.
Gregory P. Veldhuizen   +3 more
doaj   +1 more source

Screening and Diagnosis of Primary Aldosteronism in Patients Using Renin‐Angiotensin System Inhibitors

open access: yesThe Journal of Clinical Hypertension, Volume 28, Issue 1, January 2026.
ABSTRACT This study investigated whether patients receiving renin‐angiotensin system inhibitors (RASIs) can undergo reliable screening for primary aldosteronism (PA) without discontinuation of therapy. Consecutive patients with hypertension who underwent PA screening at our hospital between 2016 and 2024 while on RASIs were recruited.
Qian Wang   +4 more
wiley   +1 more source

Clinical Trial: Efficacy and Safety of Velusetrag in Chronic Intestinal Pseudo‐Obstruction: A Randomized, Phase 2, Placebo‐Controlled, Crossover, Multiple (n = 1), Proof‐of‐Concept Study

open access: yesNeurogastroenterology &Motility, Volume 38, Issue 1, January 2026.
This phase 2 proof‐of‐concept trial evaluated the efficacy and safety of velusetrag in patients with chronic intestinal pseudo‐obstruction. Velusetrag treatment was generally well tolerated and was associated with improved symptoms and a reduction in pseudo‐obstructive episodes versus placebo, although these differences did not reach statistical ...
Carolina Malagelada   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy